MarketGrader Europe 100 Index


Five Largest Companies
Symbol Name Grade Market Cap Country
ASML.NL ASML Holding NV 60.0 ¤560,701 NL
HSBA.GB HSBC Holdings Plc 52.9 ¤323,942 GB
NOVN.CH Novartis AG 57.9 ¤316,137 CH
AZN.GB AstraZeneca PLC 65.5 ¤316,072 GB
LIN Linde plc 47.5 ¤232,779 GB

Five Smallest Companies
Symbol Name Grade Market Cap Country
BIM.FR bioMerieux SA 50.2 ¤13,435 FR
SN.GB Smith & Nephew plc 59.8 ¤15,495 GB
SOON.CH Sonova Holding AG 49.1 ¤15,512 CH
ENX.FR Euronext NV 52.1 ¤16,271 NL
PNR Pentair plc 50.9 ¤16,395 GB

Companies with Most Selections Among Current Components
Symbol Name Grade Times* Country
ASML.NL ASML Holding NV 60.0 33 NL
ACN Accenture Plc Class A 60.8 32 IE
DNB.NO DNB Bank ASA 62.1 29 NO
ALV.DE Allianz SE 55.8 28 DE
LR.FR Legrand SA 61.2 28 FR
NOVO.B.DK Novo Nordisk A/S Class B 59.4 28 DK
ASSA.B.SE ASSA ABLOY AB Class B 48.8 27 SE
TEL TE Connectivity plc 64.8 26 IE
ETN Eaton Corp. Plc 60.9 25 IE
SAND.SE Sandvik AB 50.8 24 SE
*Number of times selected at Index semi-annual reconstitutions since inception date.
Index Bio
Average Market Cap ¤79,253
Median Market Cap ¤47,494
Avg. 3 Mo. Dollar Vol. ¤176,175,329
Avg. 3 Mo. Trading Vol. 5,589,982
Last Rebalance Date 09/22/2025
Companies Replaced 49
Biggest Sector Increase Health Care
Biggest Sector Decrease Utilities

Fundamental Attributes
Trailing P/E Ratio (12 Mo.) 18.5
Forward P/E Ratio (12 Mo.) 15.3
Price/Book Ratio 3.3
Avg. Revenue Chg. - 3 Yr 24.0%
Avg. Op. Income Chg. - 3 Yr. 55.2%
Avg. EPS Growth - 3 Yr. 16.9%
Avg. EPS Growth - 1 Yr. 19.6%
Avg. Operating Margin 20.1%
Avg. LT Debt to Total Capital 42.2%
Avg. Return on Equity 16.8%
Dividend Yield 1.8%
Index Average Grade
Europe 100 Index 57.48
Country Breakdown
United Kingdom 22.0%
Germany 14.0%
Switzerland 10.0%
Ireland 10.0%
Netherlands 9.0%
Sweden 7.0%
France 7.0%
Italy 6.0%
Spain 5.0%
Denmark 2.0%
Belgium 2.0%
Norway 2.0%
Luxembourg 1.0%
Hong Kong 1.0%
Austria 1.0%
Finland 1.0%
For more information on this index please contact us

Get Access to the World's Smartest Global Research Platform

Don't wait another day to make better informed, higher-returning investments.

TRY IT FOR FREE